Combination

A technology of compounds, drugs, applied in the field of combinations that can be used in this therapy, can solve problems such as uncontrolled cell proliferation

Inactive Publication Date: 2015-09-09
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Thus, hyperactivation of this pathway causes uncontrolled cell proliferation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination
  • Combination
  • Combination

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0228] Example 1 - Capsule Composition

[0229] Oral dosage forms for administering the combinations of the invention are prepared by filling standard two-part hard gelatin capsules with the ingredients in the proportions shown in Table I below.

[0230] Table I

[0231]

Embodiment 2

[0232] Example 2 - Capsule Composition

[0233] Oral dosage forms for administering one of the compounds of this invention are prepared by filling standard two-part hard gelatin capsules with the ingredients in the proportions shown in Table II below.

[0234] Table II

[0235]

Embodiment 3

[0236] Example 3 - Capsule Composition

[0237] Oral dosage forms for administering one of the compounds of this invention are prepared by filling standard two-part hard gelatin capsules with the ingredients in the proportions shown in Table III below.

[0238] Table III

[0239]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering -methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimi dazole-4-carboxylic acid, or a pharmaceutically acceptable salt thereof, and N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof.

Description

technical field [0001] The present invention relates to methods of treating cancer in mammals, and to combinations useful in such treatment. In particular, the approach involves novel combinations comprising the PI3K inhibitor: 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4- Morpholinyl)-1H-benzimidazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a MEK inhibitor: N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo -phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidine-1- Base] phenyl} acetamide or a pharmaceutically acceptable salt or solvate thereof, to a pharmaceutical composition comprising the combination, and to a method of using the combination to treat cancer. Background technique [0002] Typically, cancers arise from dysregulation of the normal processes that control cell division, differentiation, and apoptosis. Apoptosis (programmed cell death) plays an important role in embryonic development and the pat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4375A61K31/5377A61P35/00
CPCA61K31/519A61K31/5377A61P35/00A61P35/02A61K2300/00
Inventor K.E.巴克曼J.D.格雷肖克M.A.哈德威克
Owner GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap